Oxidized low-density lipoprotein activates adipophilin through ERK1/2 signal pathway in RAW264.7 cells

Acta Biochimica et Biophysica Sinica

Volumn 42, Issue 9, 2010, Pages 635-645

  Liu, Qingnan ^a,b   Dai, Zhibing ^a,c   Liu, Zhiqiang ^a   Liu, Xiaohui ^a   Tang, Chaoke ^a   Wang, Zuo ^a   Yi, Guanghui ^a   Liu, Lushan ^a   Jiang, Zhisheng ^a   Yang, Yongzong ^a   Yuan, Zhonghua ^a  

^a UNIVERSITY OF SOUTH CHINA   (China)

^b Yiyang Medical College   (China)

^c Yiyang Central Hospital   (China)

Author keywords

adipophilin; atherosclerosis; ERK1 2; PPAR

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 CHLORO 5 NITRO N (4 PYRIDYL)BENZAMIDE; ADIPOPHILIN; BENZAMIDE DERIVATIVE; FLAVONOID; LIPID; LOW DENSITY LIPOPROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; OXIDIZED LOW DENSITY LIPOPROTEIN; PEPTIDE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PYRIDINE DERIVATIVE;

ANIMAL; ARTICLE; CELL LINE; CYTOLOGY; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; GENE EXPRESSION; GENETICS; HUMAN; LIPID METABOLISM; MACROPHAGE; METABOLISM; MOUSE; PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TIME; WESTERN BLOTTING;

ANIMALS; BENZAMIDES; BLOTTING, WESTERN; CELL LINE; DOSE-RESPONSE RELATIONSHIP, DRUG; FLAVONOIDS; GENE EXPRESSION; HUMANS; LIPID METABOLISM; LIPIDS; LIPOPROTEINS, LDL; MACROPHAGES; MICE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; PEPTIDES; PHOSPHORYLATION; PPAR GAMMA; PYRIDINES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TIME FACTORS;

EID: 77956297172     PISSN: 16729145     EISSN: 17457270     Source Type: Journal    
DOI: 10.1093/abbs/gmq070     Document Type: Article

References (51)

1. Morel DW, Hessler JR and Chisholm GM. Low density lipoprotein cytotoxicity induced by free radical peroxidation of lipid. J Lipid Res 1983, 24: 1070-1076.
2. Griendling KK and Alexander RW. Oxidative stress and cardiovascular disease. Circulation 1997, 96: 3264-3265.
3. Han J, Hajjar DP, Febbraio M and Nicholson AC. Native and modified low density lipoproteins increase the functional expression of the macrophage class B scavenger receptor, CD36. J Biol Chem 1997, 272: 21654-21659.
4. Jiang HP and Serrero G. Isolation and characterization of a full-length cDNA coding for an adipose differentiation-related protein. Proc Natl Acad Sci USA 1992, 89: 7856-7860.
5. Brasaemle DL, Barber T, Wolins NE, Serrero G, Blanchette-Mackie EJ and Londos C. Adipose differentiation-related protein is an ubiquitously expressed lipid storage droplet-associated protein. J Lipid Res 1997, 38: 2249-2263.
6. Heid HW, Moll R, Schwetlick I, Rackwitz HR and Keenan TW. Adipophilin is a specific maker of lipid accumulation in diverse cell types and diseases. Cell Tissue Res 1998, 294: 309-321.
7. Londos C, Brasaemle DL, Schultz CJ, Segrest JP and Kimmel AR. Perilipins, ADRP, and other proteins that associate with intracellular neutral lipid droplets in animal cells. Semin Cell Dev Biol 1999, 10: 51-58.
8. Shiffman D, Mikita T, Tai JT, Wade DP, Porter JG, Seilhamer JJ and Somogyi R, et al. Large scale gene expression analysis of cholesterolloaded macrophages. J Biol Chem 2000, 275: 37324-37332.
9. Wang X, Reape TJ, Li X, Rayner K, Webb CL, Burnand KG and Lysko PG. Induced expression of adipophilin mRNA in human macrophages stimulated with oxidized low-density lipoprotein and in atherosclerotic lesions. FEBS Lett 1999, 462: 145-150.
10. Buechler C, Ritter M, Duong CQ, Orso E, Kapinsky M and Schmitz G. Adipophilin is a sensitive marker for lipid loading in human blood monocytes. Biochim Biophys Acta 2001, 1532: 97-104.
11. Braissant O, Foufelle F, Scotto C, Dauça M and Wahli W. Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat. Endocrinology 1996, 137: 354-366.
12. Tontonoz P, Hu E, Graves RA, Budavari AI and Spiegelman BM. mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer. Genes Dev 1994, 8: 1224-1234.
13. Tontonoz P, Hu E and Spiegelman BM. Stimulation of adipogenesis in fibroblasts by PPARgamma2, a lipid-activated transcription factor. Cell 1994, 79: 1147-1156.
14. Jones PS, Savory R, Barratt P, Bell AR, Gray TJ, Jenkins NA and Gilbert DJ, et al. Chromosomal localisation,inducibility,tissue-specific expression and strain differences in three murine peroxisome-proliferator-activatedreceptor genes. Eur J Biochem 1995, 233: 219-226.
15. Nagy L, Tontonoz P, Alvarez JG, Chen H and Evans RM. Oxidized LDL regulates macrophage gene expression through ligand activation of PPARgamma. Cell 1998, 93: 229-240.
16. Ricote M, Huang J, Fajas L, Li A, Welch J, Najib J and Witztum JL, et al. Expression of the peroxisome proliferator-activated receptor gamma (PPARgamma) in human atherosclerosis and regulation in macrophages by colony stimulating factors and oxidized low density lipoprotein. Proc Natl Acad Sci USA 1998, 95: 7614-7619.
17. Tontonoz P, Nagy L, Alvarez JG, Thomazy VA and Evans RM. PPARg promotes monocyte/macrophage differentiation and uptake of oxidized LDL. Cell 1998, 93: 241-252.
18. Taketa K, Matsumura T, Yano M, Ishii N, Senokuchi T, Motoshima H and Murata Y, et al. Oxidized low density lipoprotein activates peroxisome proliferator-activated receptor-alpha (PPARalpha) and PPARgamma through MAPK-dependent COX-2 expression in macrophages. J Biol Chem 2008, 283: 9852-9862.
19. Lee H, Shi W, Tontonoz P, Wang S, Subbanagounder G, Hedrick CC and Hama S, et al. Role for peroxisome proliferator-activated receptor alpha in oxidized phospholipid-induced synthesis of monocyte chemotactic protein-1 and interleukin-8 by endothelial cells. Circ Res 2000, 87: 516-521.
20. Johnson GL and Lapadat R. Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 2002, 298: 1911-1912.
21. Karin M. Signal transdection from the cell surface to the nucleus through the phosphorylation of transcription factors. Curr Opin Cell Biol 1994, 6: 415-424.
22. GuytonK Z, Liu Y, Gorospe M, Xu Q and Holbrook NJ. Activation of mitogen-activated protein kinase by H2O2. Role in cell survival following oxidant injury. J Biol Chem 1996, 271: 4138-4142.
23. Yano M, Matsumura T, Senokuchi T, Ishii N, Murata Y, Taketa K and Motoshima H, et al. Statins activate peroxisome proliferator-activated receptor gamma through extracellular signal-regulated kinase 1/2 and p38 mitogen-activated protein kinase-dependent cyclooxygenase-2 expression in macrophages. Circ Res 2007, 100: 1442-1451.
24. Pitulis N, Papageorgiou E, Tenta R, Lembessis PK and Outsilieris M. IL-6 and PPARgamma signalling in human PC-3 prostate cancer cells. Anticancer Res 2009, 29: 2331-2337.
25. Sung CK, She H, Xiong S and Tsukamoto H. Tumor necrosis factor-alpha inhibits peroxisome proliferator-activated receptor gamma activity at a posttranslational level in hepatic stellate cells. Am J Physiol Gastrointest Liver Physiol 2004, 286: G722-G729.
26. Demers A, Caron V, Rodrigue-Way A, Wahli W, Ong H and Tremblay A. A concerted kinase interplay identifies PPARgamma as a molecular target of ghrelin signaling in macrophages. PLoS One 2009, 4: e7728.
27. Chuang CC, Yang RS, Tsai KS, Ho FM and Liu SH. Hyperglycemia enhances adipogenic induction of lipid accumulation: involvement of extracellular signal-regulated protein kinase 1/2, phosphoinositide 3-kinase/Akt, and peroxisome proliferator-activated receptor gamma signaling. Endocrinology 2007, 148: 4267-4275.
28. Qiao JH, Tripathi J, Mishra NK, Cai Y, Tripathi S, Wang XP and Imes S, et al. Role of macrophage colony-stimulating factor in atherosclerosis:studies of osteopetrotic mice. Am J Pathol 1997, 150: 1687-1699.
29. Smith JD, Trogan E, Ginsberg M, Grigaux C, Tian J and Miyata M. Decreased atherosclerosis in mice deficient in both macrophage colony-stimulating factor (op) and apolipoprotein E. Proc Natl Acad Sci USA 1995, 92: 8264-8268.
30. Sakai M, Miyazaki A, Sakamoto Y, Shichiri M and Horiuchi S. Cross-linking of apolipoproteins is involved in a loss of the ligand activity of high density lipoprotein upon Cu(2+)-mediated oxidation. FEBS Lett 1992, 314: 199-202.
31. Noble RP. Electrophoretic separation of plasma lipoproteins in agarose gel. J Lipid Res 1968, 9: 693-700.
32. Senokuchi T, Matsumura T, Sakai M, Matsuo T, Yano M, Kiritoshi S and Sonoda K, et al. Extracellular signal-regulated kinase and p38 mitogenactivated protein kinase mediate macrophage proliferation induced by oxidized low-density lipoprotein. Atherosclerosis 2004, 176: 233-245.
33. Barrie AP, Clohessy AM, Buensuceso CS, Rogers MV and Allen JM. Pituitary adenylyl cyclase-activating peptide stimulates extracellular signalregulated kinase 1 or 2 (ERK1/2) activity in a Ras-independent, mitogenactivated protein Kinase/ERK kinase 1 or 2-dependent manner in PC12 cells. J Biol Chem 1997, 272: 19666-19671.
34. Negishi M, Shimizu H, Okada S, Kuwabara A, Okajima F and Mori M. 9HODE stimulates cell proliferation and extracellular matrix synthesis in human mesangial cells via PPARgamma. Exp Biol Med (Maywood) 2004, 229: 1053-1060.
35. Han J, Hajjar DP, Tauras JM, Feng J, Gotto AM, Jr and Nicholson AC. Transforming growth factor-beta1 (TGF-beta1) and TGF-beta2 decrease expression of CD36, the type B scavenger receptor, through mitogenactivated protein kinase phosphorylation of peroxisome proliferatoractivated receptor-gamma. J Biol Chem 2000, 275: 1241-1246.
36. Moore KJ, Rosen ED, Fitzgerald ML, Randow F, Andersson LP, Altshuler D and Milstone DS, et al. The role of PPAR-gamma in macrophage differentiation and cholesterol uptake. Nat Med 2001, 7: 41-47.
37. Larigauderie G, Furman C, Jaye M, Lasselin C, Copin C, Fruchart JC and Castro G, et al. Adipophilin enhances lipid accumulation and prevents lipid efflux from THP-1 macrophages: potential role in atherogenesis. Arterioscler Thromb Vasc Biol 2004, 24: 504-510.
38. Deigner HP and Claus R. Stimulation of mitogen activated protein kinase by LDL and oxLDL in human U-937 macrophage-like cells. FEBS Lett 1996, 385: 149-153.
39. Kusuhara M, Chait A, Cader A and Berk BC. Oxidized LDL stimulates mitogen-activated protein kinases in smooth muscle cells and macrophages. Arterioscler Thromb Vasc Biol 1997, 17: 141-148.
40. Bassa BV, Roh DD, Kirschenbaum MA and Kamanna VS. Atherogenic lipoproteins stimulate mesangial cell p42 mitogen-activated protein kinase. J Am Soc Nephrol 1998, 9: 488-496.
41. Ishida T, Haneda M, Maeda S, Koya D and Kikkawa R. Stretch-induced overproduction of fibronectin in mesangial cells is mediated by the activation of mitogen-activated protein kinase. Diabetes 1999, 8: 595-602.
42. Jenkins AJ, Velarde V, Klein RL, Joyce KC, Phillips KD, Mayfield RK and Lyons TJ, et al. Native and modified LDL activate extracellular signalregulated kinases in mesangial cells. Diabetes 2000, 49: 2160-2169.
43. Francis GA, Annicotte JS and Auwerx J. PPAR agonists in the treatment of atherosclerosis. Curr Opin Pharmacol 2003, 3: 186-191.
44. Huang WC, Chio CC, Chi KH, Wu HM and Lin WW. Superoxide aniondependent Raf/MEK/ERK activation by peroxisome proliferator activated receptor gamma agonists 15-deoxy-delta(12,14)-prostaglandin J(2), ciglitazone, and GW1929. Exp Cell Res 2002, 277: 192-200.
45. Forcheron F, Legedz L, Chinetti G, Feugier P, Letexier D, Bricca G and Beylot M. Genes of cholesterol metabolism in human atheroma: overexpression of perilipin and genes promoting cholesterol storage and repression of ABCA1 expression. Arterioscler Thromb Vasc Biol 2005, 25: 1711-1717.
46. Miura S, Gan JW, Brzostowski J, Parisi MJ, Schultz CJ, Londos C and Oliver B, et al. Functional conservation for lipid storage droplet association among Perilipin, ADRP, and TIP47 (PAT)-related proteins in mammals, Drosophila, and Dictyostelium. J Biol Chem 2002, 277: 32253-32257.
47. Chen F, Wang M, O'Connor JP, He M, Tripathi T and Harrison LE. Phosphorylation of PPARgamma via active ERK1/2 leads to its physical association with p65 and inhibition of NF-kappabeta. J Cell Biochem 2003, 90: 732-744.
48. Mei CL, He P, Cheng B, Liu W, Wang YF and Wan JJ. Chlamydia pneumoniae induces macrophage-derived foam cell formation via PPAR alpha and PPAR gamma-dependent pathways. Cell Biol Int 2009, 33: 301-308.
49. Ji YY, Liu JT, Liu N, Wang ZD and Liu CH. PPARalpha activator fenofibrate modulates angiotensin II-induced inflammatory responses in vascular smooth muscle cells via the TLR4-dependent signaling pathway. Biochem Pharmacol 2009, 78: 1186-1197.
50. Chen NG, Sarabia SF, Malloy PJ, Zhao XY, Feldman D and Reaven GM. PPARgamma agonists enhance human vascular endothelial adhesiveness by increasing ICAM-1 expression. Biochem Biophys Res Commun 1999, 263: 718-722.
51. Tontonoz P and Nagy L. Regulation of macrophage gene expression by peroxisome-proliferator-activated receptor gamma: implications for cardiovascular disease. Curr Opin Lipidol 1999, 10: 485-490.